Shares of Tivity Health Inc (NASDAQ:TVTY) have earned an average recommendation of “Buy” from the ten research firms that are covering the company, MarketBeat reports. One investment analyst has rated the stock with a sell rating, one has given a hold rating, six have assigned a buy rating and one has issued a strong buy rating on the company. The average twelve-month price objective among analysts that have issued a report on the stock in the last year is $44.83.
A number of equities research analysts have recently weighed in on TVTY shares. Zacks Investment Research lowered shares of Tivity Health from a “hold” rating to a “sell” rating in a research note on Wednesday, November 7th. Oppenheimer decreased their target price on shares of Tivity Health from $44.00 to $34.00 and set an “outperform” rating for the company in a report on Tuesday, December 11th. ValuEngine cut shares of Tivity Health from a “sell” rating to a “strong sell” rating in a report on Monday, January 7th. Chardan Capital decreased their price objective on shares of Tivity Health from $43.00 to $41.00 and set a “buy” rating for the company in a report on Tuesday, November 6th. Finally, TheStreet lowered shares of Tivity Health from a “b” rating to a “c+” rating in a research report on Wednesday, January 9th.
In related news, CEO Donato Tramuto sold 35,000 shares of the business’s stock in a transaction dated Wednesday, November 7th. The shares were sold at an average price of $38.25, for a total value of $1,338,750.00. Following the sale, the chief executive officer now directly owns 334,743 shares in the company, valued at approximately $12,803,919.75. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.73% of the stock is owned by insiders.
NASDAQ TVTY opened at $24.93 on Friday. The company has a debt-to-equity ratio of 0.15, a quick ratio of 0.98 and a current ratio of 0.98. The company has a market capitalization of $998.20 million, a price-to-earnings ratio of 14.84, a PEG ratio of 0.94 and a beta of 1.24. Tivity Health has a 1 year low of $23.71 and a 1 year high of $44.35.
Tivity Health (NASDAQ:TVTY) last issued its earnings results on Monday, November 5th. The company reported $0.59 EPS for the quarter, topping analysts’ consensus estimates of $0.57 by $0.02. The company had revenue of $151.50 million for the quarter, compared to analysts’ expectations of $153.87 million. Tivity Health had a net margin of 13.29% and a return on equity of 28.25%. The firm’s revenue was up 10.0% compared to the same quarter last year. During the same quarter last year, the company earned $0.46 EPS. As a group, research analysts forecast that Tivity Health will post 2.18 EPS for the current fiscal year.
Tivity Health Company Profile
Tivity Health, Inc provides fitness and health improvement programs in the United States. The company offers SilverSneakers senior fitness program to the members of Medicare advantage, Medicare supplement, and group retiree plans; and Prime fitness, a fitness facility access program through commercial health plans and employers.
Read More: Market Capitalization in the Stock Market
Receive News & Ratings for Tivity Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tivity Health and related companies with MarketBeat.com's FREE daily email newsletter.